Open AccessAbsolute leukocytes count and NLR as a diagnostic and prognostic biomarkers for severity of COVID-19 infection
Author(s) -
Khalid Abdelsamea Mohamedahmed,
Adam Dawoud Abakar
Publication year - 2021
Publication title -
jurnal teknologi laboratorium/jurnal teknologi laboratorium
Language(s) - English
Resource type - Journals
eISSN - 2580-0191
pISSN - 2338-5634
DOI - 10.29238/teknolabjournal.v10i1.263
Subject(s) - medicine , pandemic , covid-19 , intensive care medicine , severity of illness , disease , global health , healthcare system , triage , immunology , health care , emergency medicine , pathology , infectious disease (medical specialty) , public health , economics , economic growth
The current COVID-19 pandemic challenges not only the lack of awareness of the disease, but also the rapid diagnosis, the prediction of severe early disease, the clinical characterization of mortality and severity of patients, and the effective management that affects the global scale, resulting in low capacities of healthcare systems, the resilience of systems and global economics. Therefore, early differential diagnosis and prediction of SARS-COV-2 infection severity are needed. CRP and NLR are diagnostic markers commonly used, most available, effective, and economically used primarily to evaluate the ongoing systemic inflammatory response.